Table 4.
Multivariate analysis for risk of AKI in patients treated with low or high PEEP
Crude model | |||||
---|---|---|---|---|---|
Outcome | Comparisons | OR | 95% CI | p value | |
Acute kidney | Medium vs low | 3.75 | 0.98 | 14.39 | 0.0541 |
injury or failure | High vs. low | 8.33 | 2.45 | 28.29 | 0.0007 |
Adjusted model | |||||
---|---|---|---|---|---|
Outcome | Comparisons | OR | 95% CI | p value | |
Acute kidney injury or failure | Medium vs. low | 1.91 | 0.35 | 10.48 | 0.454 |
High vs low | 4.96 | 1.13 | 21.91 | 0.034 | |
Confounders | |||||
Male | 0.64 | 0.13 | 3.12 | 0.580 | |
SOFA score | 1.09 | 0.91 | 1.32 | 0.347 | |
Creatinine | 2.61 | 0.61 | 11.23 | 0.198 | |
CRP | 1.00 | 1.00 | 1.01 | 0.744 | |
Cardiovascular disease | 2.80 | 0.88 | 8.89 | 0.081 |
Logistic regression models to assess the association between AKI within 7 days after admission and average PEEP level applied during the first 7 days after admission modeling the probability of having AKI-Injury or failure against the likelihood of AKI-Risk and no-AKI. Multivariate analyses, adjusting for baseline characteristics known a priori to be potential confounders and factors associated with both exposure to PEEP and outcome. Odds ratio (OR), 95% CIs, and p values. Low-PEEP group: 9.6 [8.0–10.5] cmH2O; medium-PEEP group: 12.0 [11.2–12.7] cmH2O; high-PEEP group 14.7 [13.7–16.7] cmH2O